Breakthrough drug for Alzheimers suffers
Play
Stop
Exciting breakthroughs in Alzheimer’s disease research have led to the development of a new drugs called donanemab…which has shown promising results in slowing the progression of the disease by up to 35% in early-stage patients.
The medical community is enthusiastic about these developments, and the findings offer hope for patients and families affected by the devastating condition.
(Visited 54 times, 1 visits today)
Download Audio